X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4919) 4919
Publication (726) 726
Book Review (56) 56
Newsletter (28) 28
Newspaper Article (23) 23
Magazine Article (13) 13
Dissertation (9) 9
Book / eBook (6) 6
Trade Publication Article (5) 5
Book Chapter (4) 4
Government Document (3) 3
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3745) 3745
hepatitis (2594) 2594
male (2424) 2424
female (2317) 2317
index medicus (2202) 2202
adult (1958) 1958
middle aged (1752) 1752
hepatitis c (1351) 1351
medicine, general & internal (1110) 1110
risk factors (871) 871
health aspects (778) 778
infections (760) 760
aged (719) 719
hepatitis c virus (710) 710
prevalence (660) 660
research (629) 629
public, environmental & occupational health (611) 611
hepatitis b (599) 599
psychiatry (580) 580
liver diseases (571) 571
patients (571) 571
infection (562) 562
liver (550) 550
antiviral agents - therapeutic use (547) 547
adolescent (538) 538
care and treatment (534) 534
hiv (518) 518
studies (517) 517
interferon (502) 502
public health (501) 501
virus-infection (494) 494
human immunodeficiency virus--hiv (490) 490
young adult (484) 484
hepatitis c, chronic - drug therapy (483) 483
analysis (473) 473
drug therapy (459) 459
mortality (451) 451
quality of life (451) 451
surveys and questionnaires (447) 447
substance abuse (432) 432
abridged index medicus (427) 427
hepatitis c, chronic - psychology (425) 425
infectious diseases (405) 405
medical research (405) 405
prevention (405) 405
liver cancer (401) 401
disease (398) 398
united-states (398) 398
article (392) 392
viruses (392) 392
depression (390) 390
gastroenterology & hepatology (379) 379
epidemiology (365) 365
therapy (365) 365
liver cirrhosis (351) 351
risk (337) 337
medicine & public health (331) 331
quality-of-life (330) 330
cross-sectional studies (327) 327
hepatitis-c (320) 320
cirrhosis (314) 314
hepatitis c - epidemiology (313) 313
diagnosis (310) 310
cancer (306) 306
interferon-alpha - therapeutic use (305) 305
drug use (301) 301
research article (301) 301
antiviral agents - adverse effects (296) 296
hepatitis b virus (293) 293
internal medicine (293) 293
comorbidity (292) 292
treatment outcome (291) 291
psychology (290) 290
hepatitis c - complications (282) 282
medicine (282) 282
hepatitis c - psychology (271) 271
health knowledge, attitudes, practice (265) 265
health (250) 250
prospective studies (250) 250
ribavirin (247) 247
chronic hepatitis-c (246) 246
virus diseases (246) 246
drug abuse (245) 245
hospitals (237) 237
interferon-alpha - adverse effects (237) 237
drug therapy, combination (236) 236
hepatitis c - drug therapy (236) 236
health policy & services (230) 230
population (228) 228
hepatitis c, chronic - complications (226) 226
oncology (223) 223
hepatitis-c virus (220) 220
immunization (218) 218
proteins (218) 218
immunology (217) 217
impact (216) 216
animals (215) 215
management (215) 215
ribavirin - therapeutic use (214) 214
antigens (208) 208
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4936) 4936
French (23) 23
German (10) 10
Chinese (9) 9
Russian (6) 6
Spanish (5) 5
Japanese (4) 4
Polish (4) 4
Portuguese (4) 4
Korean (3) 3
Serbian (3) 3
Danish (2) 2
Arabic (1) 1
Hungarian (1) 1
Italian (1) 1
Norwegian (1) 1
Romanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Psychiatry, ISSN 1359-4184, 08/2012, Volume 17, Issue 8, pp. 781 - 789
Interferon (IFN)-alpha treatment for infectious diseases and cancer is associated with significant depressive symptoms that can limit therapeutic efficacy.... 
cytokines | depression | interferon-α | genes | single nucleotide polymorphism | indoleamine-2,3-dioxygenase | HUMAN MICROGLIA | ACTIVATION | KYNURENINE PATHWAY | PSYCHIATRY | BIOCHEMISTRY & MOLECULAR BIOLOGY | INDOLEAMINE 2,3-DIOXYGENASE | SYMPTOMS | NEUROSCIENCES | QUINOLINIC ACID | DECREASED SERUM TRYPTOPHAN | interferon-alpha | SEROTONIN | IFN-ALPHA | Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics | Randomized Controlled Trials as Topic - psychology | Randomized Controlled Trials as Topic - methods | Humans | Middle Aged | Polyethylene Glycols - adverse effects | Male | Hepatitis C, Chronic - complications | Recombinant Proteins - adverse effects | Depression - genetics | Promoter Regions, Genetic - genetics | European Continental Ancestry Group - psychology | Psychiatric Status Rating Scales | Adult | Depression - complications | Female | Genetic Predisposition to Disease - psychology | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease - genetics | African Americans - genetics | Genotype | Hepatitis C, Chronic - drug therapy | Polymorphism, Genetic | Antiviral Agents - adverse effects | Alleles | Depression - psychology | Interferon-alpha - adverse effects | Hepatitis C, Chronic - psychology | African Americans - psychology | Clinical trials | Depression | Single-nucleotide polymorphism | Gene polymorphism | Promoters | Risk factors | Homozygotes | Neurotransmitters | Infectious diseases | Ethnic groups | alpha -Interferon | Hepatitis C | Cancer | indoleamine-2 | 3-dioxygenase
Journal Article
Journal Article
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2010, Volume 8, Issue 12, pp. 1017 - 1029
Journal Article
Clinics in Liver Disease, ISSN 1089-3261, 08/2017, Volume 21, Issue 3, pp. 517 - 534
Hepatitis C virus (HCV) infection is a systemic disease with hepatic and extrahepatic manifestations, including neuropsychiatric conditions. Depression is a... 
Depression | HCV | Quality of life